Pharma & Healthcare
Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2026
- Mar 14, 26
- ID: 729696
- Pages: 140
- Figures: 141
- Views: 11
This report delivers a comprehensive overview of the global GLP-1 Targeted Peptide Weight Loss Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding GLP-1 Targeted Peptide Weight Loss Drugs. The GLP-1 Targeted Peptide Weight Loss Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global GLP-1 Targeted Peptide Weight Loss Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GLP-1 Targeted Peptide Weight Loss Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
Astra Zeneca
Baxter Pharmaceutical
Nano Precision Medical
Zealand Pharma
Sanofi-Aventis
iX Biopharma
Lexaria Bioscience
Chugai Pharmaceutical
HIKMA PHARMS
Amylin Pharmaceuticals
Orbis Biosciences
Intarcia Therapeutics
Nanexa AB
The General Hospital Corp
QuiaPEG Pharmaceuticals Ab
Qilu Pharmaceutical
Huadong Medicine
Jiuyuan Gene Engineering
Benemae Pharmaceutical
Segment by Type
Liraglutide
Semaglutide
Tirzepatide
Others
by Application
Treatment of Type 2 Diabetes
Obesity and Weight Management
Cardiovascular Risk
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for GLP-1 Targeted Peptide Weight Loss Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines GLP-1 Targeted Peptide Weight Loss Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global GLP-1 Targeted Peptide Weight Loss Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GLP-1 Targeted Peptide Weight Loss Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
Astra Zeneca
Baxter Pharmaceutical
Nano Precision Medical
Zealand Pharma
Sanofi-Aventis
iX Biopharma
Lexaria Bioscience
Chugai Pharmaceutical
HIKMA PHARMS
Amylin Pharmaceuticals
Orbis Biosciences
Intarcia Therapeutics
Nanexa AB
The General Hospital Corp
QuiaPEG Pharmaceuticals Ab
Qilu Pharmaceutical
Huadong Medicine
Jiuyuan Gene Engineering
Benemae Pharmaceutical
Segment by Type
Liraglutide
Semaglutide
Tirzepatide
Others
by Application
Treatment of Type 2 Diabetes
Obesity and Weight Management
Cardiovascular Risk
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for GLP-1 Targeted Peptide Weight Loss Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines GLP-1 Targeted Peptide Weight Loss Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 GLP-1 Targeted Peptide Weight Loss Drugs Market Overview
1.1 Product Definition
1.2 GLP-1 Targeted Peptide Weight Loss Drugs by Type
1.2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Type: 2025 vs 2032
1.2.2 Liraglutide
1.2.3 Semaglutide
1.2.4 Tirzepatide
1.2.5 Others
1.3 GLP-1 Targeted Peptide Weight Loss Drugs by Application
1.3.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Application: 2025 vs 2032
1.3.2 Treatment of Type 2 Diabetes
1.3.3 Obesity and Weight Management
1.3.4 Cardiovascular Risk
1.4 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue 2021–2032
1.4.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales 2021–2032
1.4.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 GLP-1 Targeted Peptide Weight Loss Drugs Market Competition by Manufacturers
2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of GLP-1 Targeted Peptide Weight Loss Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Product Types and Applications
2.7 Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Date of Entry into the Industry
2.8 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Competitive Situation and Trends
2.8.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global GLP-1 Targeted Peptide Weight Loss Drugs Players Market Share by Revenue
2.8.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Scenario by Region
3.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region: 2021–2032
3.2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region: 2021–2026
3.2.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region: 2027–2032
3.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region: 2021–2032
3.3.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region: 2021–2026
3.3.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region: 2027–2032
3.4 North America GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Country
3.4.1 North America GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (2021–2032)
3.4.3 North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Country
3.5.1 Europe GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (2021–2032)
3.5.3 Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (2021–2032)
3.7.3 Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Type (2021–2032)
4.1.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Type (2021–2026)
4.1.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Type (2027–2032)
4.1.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Type (2021–2032)
4.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Type (2021–2032)
4.2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Type (2021–2026)
4.2.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Type (2027–2032)
4.2.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Type (2021–2032)
4.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Application (2021–2032)
5.1.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Application (2021–2026)
5.1.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Application (2027–2032)
5.1.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Application (2021–2032)
5.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Application (2021–2032)
5.2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Application (2021–2026)
5.2.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Application (2027–2032)
5.2.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Application (2021–2032)
5.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novo Nordisk GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eli Lilly GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Astra Zeneca
6.3.1 Astra Zeneca Company Information
6.3.2 Astra Zeneca Description and Business Overview
6.3.3 Astra Zeneca GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Astra Zeneca GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.3.5 Astra Zeneca Recent Developments/Updates
6.4 Baxter Pharmaceutical
6.4.1 Baxter Pharmaceutical Company Information
6.4.2 Baxter Pharmaceutical Description and Business Overview
6.4.3 Baxter Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Baxter Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.4.5 Baxter Pharmaceutical Recent Developments/Updates
6.5 Nano Precision Medical
6.5.1 Nano Precision Medical Company Information
6.5.2 Nano Precision Medical Description and Business Overview
6.5.3 Nano Precision Medical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Nano Precision Medical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.5.5 Nano Precision Medical Recent Developments/Updates
6.6 Zealand Pharma
6.6.1 Zealand Pharma Company Information
6.6.2 Zealand Pharma Description and Business Overview
6.6.3 Zealand Pharma GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Zealand Pharma GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.6.5 Zealand Pharma Recent Developments/Updates
6.7 Sanofi-Aventis
6.7.1 Sanofi-Aventis Company Information
6.7.2 Sanofi-Aventis Description and Business Overview
6.7.3 Sanofi-Aventis GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sanofi-Aventis GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.7.5 Sanofi-Aventis Recent Developments/Updates
6.8 iX Biopharma
6.8.1 iX Biopharma Company Information
6.8.2 iX Biopharma Description and Business Overview
6.8.3 iX Biopharma GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 iX Biopharma GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.8.5 iX Biopharma Recent Developments/Updates
6.9 Lexaria Bioscience
6.9.1 Lexaria Bioscience Company Information
6.9.2 Lexaria Bioscience Description and Business Overview
6.9.3 Lexaria Bioscience GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Lexaria Bioscience GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.9.5 Lexaria Bioscience Recent Developments/Updates
6.10 Chugai Pharmaceutical
6.10.1 Chugai Pharmaceutical Company Information
6.10.2 Chugai Pharmaceutical Description and Business Overview
6.10.3 Chugai Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Chugai Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.10.5 Chugai Pharmaceutical Recent Developments/Updates
6.11 HIKMA PHARMS
6.11.1 HIKMA PHARMS Company Information
6.11.2 HIKMA PHARMS Description and Business Overview
6.11.3 HIKMA PHARMS GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 HIKMA PHARMS GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.11.5 HIKMA PHARMS Recent Developments/Updates
6.12 Amylin Pharmaceuticals
6.12.1 Amylin Pharmaceuticals Company Information
6.12.2 Amylin Pharmaceuticals Description and Business Overview
6.12.3 Amylin Pharmaceuticals GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Amylin Pharmaceuticals GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.12.5 Amylin Pharmaceuticals Recent Developments/Updates
6.13 Orbis Biosciences
6.13.1 Orbis Biosciences Company Information
6.13.2 Orbis Biosciences Description and Business Overview
6.13.3 Orbis Biosciences GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Orbis Biosciences GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.13.5 Orbis Biosciences Recent Developments/Updates
6.14 Intarcia Therapeutics
6.14.1 Intarcia Therapeutics Company Information
6.14.2 Intarcia Therapeutics Description and Business Overview
6.14.3 Intarcia Therapeutics GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Intarcia Therapeutics GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.14.5 Intarcia Therapeutics Recent Developments/Updates
6.15 Nanexa AB
6.15.1 Nanexa AB Company Information
6.15.2 Nanexa AB Description and Business Overview
6.15.3 Nanexa AB GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Nanexa AB GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.15.5 Nanexa AB Recent Developments/Updates
6.16 The General Hospital Corp
6.16.1 The General Hospital Corp Company Information
6.16.2 The General Hospital Corp Description and Business Overview
6.16.3 The General Hospital Corp GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 The General Hospital Corp GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.16.5 The General Hospital Corp Recent Developments/Updates
6.17 QuiaPEG Pharmaceuticals Ab
6.17.1 QuiaPEG Pharmaceuticals Ab Company Information
6.17.2 QuiaPEG Pharmaceuticals Ab Description and Business Overview
6.17.3 QuiaPEG Pharmaceuticals Ab GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 QuiaPEG Pharmaceuticals Ab GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.17.5 QuiaPEG Pharmaceuticals Ab Recent Developments/Updates
6.18 Qilu Pharmaceutical
6.18.1 Qilu Pharmaceutical Company Information
6.18.2 Qilu Pharmaceutical Description and Business Overview
6.18.3 Qilu Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Qilu Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.18.5 Qilu Pharmaceutical Recent Developments/Updates
6.19 Huadong Medicine
6.19.1 Huadong Medicine Company Information
6.19.2 Huadong Medicine Description and Business Overview
6.19.3 Huadong Medicine GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Huadong Medicine GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.19.5 Huadong Medicine Recent Developments/Updates
6.20 Jiuyuan Gene Engineering
6.20.1 Jiuyuan Gene Engineering Company Information
6.20.2 Jiuyuan Gene Engineering Description and Business Overview
6.20.3 Jiuyuan Gene Engineering GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Jiuyuan Gene Engineering GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.20.5 Jiuyuan Gene Engineering Recent Developments/Updates
6.21 Benemae Pharmaceutical
6.21.1 Benemae Pharmaceutical Company Information
6.21.2 Benemae Pharmaceutical Description and Business Overview
6.21.3 Benemae Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Benemae Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.21.5 Benemae Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Targeted Peptide Weight Loss Drugs Industry Chain Analysis
7.2 GLP-1 Targeted Peptide Weight Loss Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Targeted Peptide Weight Loss Drugs Production Mode & Process Analysis
7.4 GLP-1 Targeted Peptide Weight Loss Drugs Sales and Marketing
7.4.1 GLP-1 Targeted Peptide Weight Loss Drugs Sales Channels
7.4.2 GLP-1 Targeted Peptide Weight Loss Drugs Distributors
7.5 GLP-1 Targeted Peptide Weight Loss Drugs Customer Analysis
8 GLP-1 Targeted Peptide Weight Loss Drugs Market Dynamics
8.1 GLP-1 Targeted Peptide Weight Loss Drugs Industry Trends
8.2 GLP-1 Targeted Peptide Weight Loss Drugs Market Drivers
8.3 GLP-1 Targeted Peptide Weight Loss Drugs Market Challenges
8.4 GLP-1 Targeted Peptide Weight Loss Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 GLP-1 Targeted Peptide Weight Loss Drugs by Type
1.2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Type: 2025 vs 2032
1.2.2 Liraglutide
1.2.3 Semaglutide
1.2.4 Tirzepatide
1.2.5 Others
1.3 GLP-1 Targeted Peptide Weight Loss Drugs by Application
1.3.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Application: 2025 vs 2032
1.3.2 Treatment of Type 2 Diabetes
1.3.3 Obesity and Weight Management
1.3.4 Cardiovascular Risk
1.4 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue 2021–2032
1.4.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales 2021–2032
1.4.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 GLP-1 Targeted Peptide Weight Loss Drugs Market Competition by Manufacturers
2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of GLP-1 Targeted Peptide Weight Loss Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Product Types and Applications
2.7 Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Date of Entry into the Industry
2.8 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Competitive Situation and Trends
2.8.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global GLP-1 Targeted Peptide Weight Loss Drugs Players Market Share by Revenue
2.8.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Scenario by Region
3.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region: 2021–2032
3.2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region: 2021–2026
3.2.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region: 2027–2032
3.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region: 2021–2032
3.3.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region: 2021–2026
3.3.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region: 2027–2032
3.4 North America GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Country
3.4.1 North America GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (2021–2032)
3.4.3 North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Country
3.5.1 Europe GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (2021–2032)
3.5.3 Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (2021–2032)
3.7.3 Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Type (2021–2032)
4.1.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Type (2021–2026)
4.1.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Type (2027–2032)
4.1.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Type (2021–2032)
4.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Type (2021–2032)
4.2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Type (2021–2026)
4.2.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Type (2027–2032)
4.2.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Type (2021–2032)
4.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Application (2021–2032)
5.1.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Application (2021–2026)
5.1.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Application (2027–2032)
5.1.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Application (2021–2032)
5.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Application (2021–2032)
5.2.1 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Application (2021–2026)
5.2.2 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Application (2027–2032)
5.2.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Application (2021–2032)
5.3 Global GLP-1 Targeted Peptide Weight Loss Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novo Nordisk GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eli Lilly GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Astra Zeneca
6.3.1 Astra Zeneca Company Information
6.3.2 Astra Zeneca Description and Business Overview
6.3.3 Astra Zeneca GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Astra Zeneca GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.3.5 Astra Zeneca Recent Developments/Updates
6.4 Baxter Pharmaceutical
6.4.1 Baxter Pharmaceutical Company Information
6.4.2 Baxter Pharmaceutical Description and Business Overview
6.4.3 Baxter Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Baxter Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.4.5 Baxter Pharmaceutical Recent Developments/Updates
6.5 Nano Precision Medical
6.5.1 Nano Precision Medical Company Information
6.5.2 Nano Precision Medical Description and Business Overview
6.5.3 Nano Precision Medical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Nano Precision Medical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.5.5 Nano Precision Medical Recent Developments/Updates
6.6 Zealand Pharma
6.6.1 Zealand Pharma Company Information
6.6.2 Zealand Pharma Description and Business Overview
6.6.3 Zealand Pharma GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Zealand Pharma GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.6.5 Zealand Pharma Recent Developments/Updates
6.7 Sanofi-Aventis
6.7.1 Sanofi-Aventis Company Information
6.7.2 Sanofi-Aventis Description and Business Overview
6.7.3 Sanofi-Aventis GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sanofi-Aventis GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.7.5 Sanofi-Aventis Recent Developments/Updates
6.8 iX Biopharma
6.8.1 iX Biopharma Company Information
6.8.2 iX Biopharma Description and Business Overview
6.8.3 iX Biopharma GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 iX Biopharma GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.8.5 iX Biopharma Recent Developments/Updates
6.9 Lexaria Bioscience
6.9.1 Lexaria Bioscience Company Information
6.9.2 Lexaria Bioscience Description and Business Overview
6.9.3 Lexaria Bioscience GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Lexaria Bioscience GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.9.5 Lexaria Bioscience Recent Developments/Updates
6.10 Chugai Pharmaceutical
6.10.1 Chugai Pharmaceutical Company Information
6.10.2 Chugai Pharmaceutical Description and Business Overview
6.10.3 Chugai Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Chugai Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.10.5 Chugai Pharmaceutical Recent Developments/Updates
6.11 HIKMA PHARMS
6.11.1 HIKMA PHARMS Company Information
6.11.2 HIKMA PHARMS Description and Business Overview
6.11.3 HIKMA PHARMS GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 HIKMA PHARMS GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.11.5 HIKMA PHARMS Recent Developments/Updates
6.12 Amylin Pharmaceuticals
6.12.1 Amylin Pharmaceuticals Company Information
6.12.2 Amylin Pharmaceuticals Description and Business Overview
6.12.3 Amylin Pharmaceuticals GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Amylin Pharmaceuticals GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.12.5 Amylin Pharmaceuticals Recent Developments/Updates
6.13 Orbis Biosciences
6.13.1 Orbis Biosciences Company Information
6.13.2 Orbis Biosciences Description and Business Overview
6.13.3 Orbis Biosciences GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Orbis Biosciences GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.13.5 Orbis Biosciences Recent Developments/Updates
6.14 Intarcia Therapeutics
6.14.1 Intarcia Therapeutics Company Information
6.14.2 Intarcia Therapeutics Description and Business Overview
6.14.3 Intarcia Therapeutics GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Intarcia Therapeutics GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.14.5 Intarcia Therapeutics Recent Developments/Updates
6.15 Nanexa AB
6.15.1 Nanexa AB Company Information
6.15.2 Nanexa AB Description and Business Overview
6.15.3 Nanexa AB GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Nanexa AB GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.15.5 Nanexa AB Recent Developments/Updates
6.16 The General Hospital Corp
6.16.1 The General Hospital Corp Company Information
6.16.2 The General Hospital Corp Description and Business Overview
6.16.3 The General Hospital Corp GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 The General Hospital Corp GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.16.5 The General Hospital Corp Recent Developments/Updates
6.17 QuiaPEG Pharmaceuticals Ab
6.17.1 QuiaPEG Pharmaceuticals Ab Company Information
6.17.2 QuiaPEG Pharmaceuticals Ab Description and Business Overview
6.17.3 QuiaPEG Pharmaceuticals Ab GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 QuiaPEG Pharmaceuticals Ab GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.17.5 QuiaPEG Pharmaceuticals Ab Recent Developments/Updates
6.18 Qilu Pharmaceutical
6.18.1 Qilu Pharmaceutical Company Information
6.18.2 Qilu Pharmaceutical Description and Business Overview
6.18.3 Qilu Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Qilu Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.18.5 Qilu Pharmaceutical Recent Developments/Updates
6.19 Huadong Medicine
6.19.1 Huadong Medicine Company Information
6.19.2 Huadong Medicine Description and Business Overview
6.19.3 Huadong Medicine GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Huadong Medicine GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.19.5 Huadong Medicine Recent Developments/Updates
6.20 Jiuyuan Gene Engineering
6.20.1 Jiuyuan Gene Engineering Company Information
6.20.2 Jiuyuan Gene Engineering Description and Business Overview
6.20.3 Jiuyuan Gene Engineering GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Jiuyuan Gene Engineering GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.20.5 Jiuyuan Gene Engineering Recent Developments/Updates
6.21 Benemae Pharmaceutical
6.21.1 Benemae Pharmaceutical Company Information
6.21.2 Benemae Pharmaceutical Description and Business Overview
6.21.3 Benemae Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Benemae Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product Portfolio
6.21.5 Benemae Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Targeted Peptide Weight Loss Drugs Industry Chain Analysis
7.2 GLP-1 Targeted Peptide Weight Loss Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Targeted Peptide Weight Loss Drugs Production Mode & Process Analysis
7.4 GLP-1 Targeted Peptide Weight Loss Drugs Sales and Marketing
7.4.1 GLP-1 Targeted Peptide Weight Loss Drugs Sales Channels
7.4.2 GLP-1 Targeted Peptide Weight Loss Drugs Distributors
7.5 GLP-1 Targeted Peptide Weight Loss Drugs Customer Analysis
8 GLP-1 Targeted Peptide Weight Loss Drugs Market Dynamics
8.1 GLP-1 Targeted Peptide Weight Loss Drugs Industry Trends
8.2 GLP-1 Targeted Peptide Weight Loss Drugs Market Drivers
8.3 GLP-1 Targeted Peptide Weight Loss Drugs Market Challenges
8.4 GLP-1 Targeted Peptide Weight Loss Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market GLP-1 Targeted Peptide Weight Loss Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of GLP-1 Targeted Peptide Weight Loss Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GLP-1 Targeted Peptide Weight Loss Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on GLP-1 Targeted Peptide Weight Loss Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (K Units), 2021–2026
Table 18. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Region (2021–2026)
Table 19. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (K Units), 2027–2032
Table 20. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Region (2027–2032)
Table 21. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2021–2026
Table 27. North America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2027–2032
Table 28. North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Type (2021–2026)
Table 53. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Type (2027–2032)
Table 54. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Application (2021–2026)
Table 63. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Application (2027–2032)
Table 64. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novo Nordisk GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Astra Zeneca Company Information
Table 81. Astra Zeneca Description and Business Overview
Table 82. Astra Zeneca GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Astra Zeneca GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 84. Astra Zeneca Recent Developments/Updates
Table 85. Baxter Pharmaceutical Company Information
Table 86. Baxter Pharmaceutical Description and Business Overview
Table 87. Baxter Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Baxter Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 89. Baxter Pharmaceutical Recent Developments/Updates
Table 90. Nano Precision Medical Company Information
Table 91. Nano Precision Medical Description and Business Overview
Table 92. Nano Precision Medical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Nano Precision Medical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 94. Nano Precision Medical Recent Developments/Updates
Table 95. Zealand Pharma Company Information
Table 96. Zealand Pharma Description and Business Overview
Table 97. Zealand Pharma GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Zealand Pharma GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 99. Zealand Pharma Recent Developments/Updates
Table 100. Sanofi-Aventis Company Information
Table 101. Sanofi-Aventis Description and Business Overview
Table 102. Sanofi-Aventis GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sanofi-Aventis GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 104. Sanofi-Aventis Recent Developments/Updates
Table 105. iX Biopharma Company Information
Table 106. iX Biopharma Description and Business Overview
Table 107. iX Biopharma GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. iX Biopharma GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 109. iX Biopharma Recent Developments/Updates
Table 110. Lexaria Bioscience Company Information
Table 111. Lexaria Bioscience Description and Business Overview
Table 112. Lexaria Bioscience GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Lexaria Bioscience GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 114. Lexaria Bioscience Recent Developments/Updates
Table 115. Chugai Pharmaceutical Company Information
Table 116. Chugai Pharmaceutical Description and Business Overview
Table 117. Chugai Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chugai Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 119. Chugai Pharmaceutical Recent Developments/Updates
Table 120. HIKMA PHARMS Company Information
Table 121. HIKMA PHARMS Description and Business Overview
Table 122. HIKMA PHARMS GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. HIKMA PHARMS GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 124. HIKMA PHARMS Recent Developments/Updates
Table 125. Amylin Pharmaceuticals Company Information
Table 126. Amylin Pharmaceuticals Description and Business Overview
Table 127. Amylin Pharmaceuticals GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Amylin Pharmaceuticals GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 129. Amylin Pharmaceuticals Recent Developments/Updates
Table 130. Orbis Biosciences Company Information
Table 131. Orbis Biosciences Description and Business Overview
Table 132. Orbis Biosciences GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Orbis Biosciences GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 134. Orbis Biosciences Recent Developments/Updates
Table 135. Intarcia Therapeutics Company Information
Table 136. Intarcia Therapeutics Description and Business Overview
Table 137. Intarcia Therapeutics GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Intarcia Therapeutics GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 139. Intarcia Therapeutics Recent Developments/Updates
Table 140. Nanexa AB Company Information
Table 141. Nanexa AB Description and Business Overview
Table 142. Nanexa AB GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Nanexa AB GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 144. Nanexa AB Recent Developments/Updates
Table 145. The General Hospital Corp Company Information
Table 146. The General Hospital Corp Description and Business Overview
Table 147. The General Hospital Corp GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. The General Hospital Corp GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 149. The General Hospital Corp Recent Developments/Updates
Table 150. QuiaPEG Pharmaceuticals Ab Company Information
Table 151. QuiaPEG Pharmaceuticals Ab Description and Business Overview
Table 152. QuiaPEG Pharmaceuticals Ab GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. QuiaPEG Pharmaceuticals Ab GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 154. QuiaPEG Pharmaceuticals Ab Recent Developments/Updates
Table 155. Qilu Pharmaceutical Company Information
Table 156. Qilu Pharmaceutical Description and Business Overview
Table 157. Qilu Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Qilu Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 159. Qilu Pharmaceutical Recent Developments/Updates
Table 160. Huadong Medicine Company Information
Table 161. Huadong Medicine Description and Business Overview
Table 162. Huadong Medicine GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Huadong Medicine GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 164. Huadong Medicine Recent Developments/Updates
Table 165. Jiuyuan Gene Engineering Company Information
Table 166. Jiuyuan Gene Engineering Description and Business Overview
Table 167. Jiuyuan Gene Engineering GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Jiuyuan Gene Engineering GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 169. Jiuyuan Gene Engineering Recent Developments/Updates
Table 170. Benemae Pharmaceutical Company Information
Table 171. Benemae Pharmaceutical Description and Business Overview
Table 172. Benemae Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Benemae Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 174. Benemae Pharmaceutical Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. GLP-1 Targeted Peptide Weight Loss Drugs Distributors List
Table 178. GLP-1 Targeted Peptide Weight Loss Drugs Customers List
Table 179. GLP-1 Targeted Peptide Weight Loss Drugs Market Trends
Table 180. GLP-1 Targeted Peptide Weight Loss Drugs Market Drivers
Table 181. GLP-1 Targeted Peptide Weight Loss Drugs Market Challenges
Table 182. GLP-1 Targeted Peptide Weight Loss Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of GLP-1 Targeted Peptide Weight Loss Drugs
Figure 2. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Share by Type: 2025 & 2032
Figure 4. Liraglutide Product Picture
Figure 5. Semaglutide Product Picture
Figure 6. Tirzepatide Product Picture
Figure 7. Others Product Picture
Figure 8. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Share by Application: 2025 & 2032
Figure 10. Treatment of Type 2 Diabetes
Figure 11. Obesity and Weight Management
Figure 12. Cardiovascular Risk
Figure 13. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), 2021–2032
Figure 16. Global GLP-1 Targeted Peptide Weight Loss Drugs Average Price (US$/Unit), 2021–2032
Figure 17. GLP-1 Targeted Peptide Weight Loss Drugs Report Years Considered
Figure 18. GLP-1 Targeted Peptide Weight Loss Drugs Sales Share by Manufacturers in 2025
Figure 19. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global GLP-1 Targeted Peptide Weight Loss Drugs Players: Market Share by Revenue in GLP-1 Targeted Peptide Weight Loss Drugs in 2025
Figure 21. GLP-1 Targeted Peptide Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of GLP-1 Targeted Peptide Weight Loss Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of GLP-1 Targeted Peptide Weight Loss Drugs by Type (2021–2032)
Figure 56. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of GLP-1 Targeted Peptide Weight Loss Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of GLP-1 Targeted Peptide Weight Loss Drugs by Application (2021–2032)
Figure 59. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. GLP-1 Targeted Peptide Weight Loss Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market GLP-1 Targeted Peptide Weight Loss Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of GLP-1 Targeted Peptide Weight Loss Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of GLP-1 Targeted Peptide Weight Loss Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GLP-1 Targeted Peptide Weight Loss Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on GLP-1 Targeted Peptide Weight Loss Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (K Units), 2021–2026
Table 18. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Region (2021–2026)
Table 19. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (K Units), 2027–2032
Table 20. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Region (2027–2032)
Table 21. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2021–2026
Table 27. North America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2027–2032
Table 28. North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Type (2021–2026)
Table 53. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Type (2027–2032)
Table 54. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Application (2021–2026)
Table 63. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Application (2027–2032)
Table 64. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novo Nordisk GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Astra Zeneca Company Information
Table 81. Astra Zeneca Description and Business Overview
Table 82. Astra Zeneca GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Astra Zeneca GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 84. Astra Zeneca Recent Developments/Updates
Table 85. Baxter Pharmaceutical Company Information
Table 86. Baxter Pharmaceutical Description and Business Overview
Table 87. Baxter Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Baxter Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 89. Baxter Pharmaceutical Recent Developments/Updates
Table 90. Nano Precision Medical Company Information
Table 91. Nano Precision Medical Description and Business Overview
Table 92. Nano Precision Medical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Nano Precision Medical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 94. Nano Precision Medical Recent Developments/Updates
Table 95. Zealand Pharma Company Information
Table 96. Zealand Pharma Description and Business Overview
Table 97. Zealand Pharma GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Zealand Pharma GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 99. Zealand Pharma Recent Developments/Updates
Table 100. Sanofi-Aventis Company Information
Table 101. Sanofi-Aventis Description and Business Overview
Table 102. Sanofi-Aventis GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sanofi-Aventis GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 104. Sanofi-Aventis Recent Developments/Updates
Table 105. iX Biopharma Company Information
Table 106. iX Biopharma Description and Business Overview
Table 107. iX Biopharma GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. iX Biopharma GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 109. iX Biopharma Recent Developments/Updates
Table 110. Lexaria Bioscience Company Information
Table 111. Lexaria Bioscience Description and Business Overview
Table 112. Lexaria Bioscience GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Lexaria Bioscience GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 114. Lexaria Bioscience Recent Developments/Updates
Table 115. Chugai Pharmaceutical Company Information
Table 116. Chugai Pharmaceutical Description and Business Overview
Table 117. Chugai Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chugai Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 119. Chugai Pharmaceutical Recent Developments/Updates
Table 120. HIKMA PHARMS Company Information
Table 121. HIKMA PHARMS Description and Business Overview
Table 122. HIKMA PHARMS GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. HIKMA PHARMS GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 124. HIKMA PHARMS Recent Developments/Updates
Table 125. Amylin Pharmaceuticals Company Information
Table 126. Amylin Pharmaceuticals Description and Business Overview
Table 127. Amylin Pharmaceuticals GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Amylin Pharmaceuticals GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 129. Amylin Pharmaceuticals Recent Developments/Updates
Table 130. Orbis Biosciences Company Information
Table 131. Orbis Biosciences Description and Business Overview
Table 132. Orbis Biosciences GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Orbis Biosciences GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 134. Orbis Biosciences Recent Developments/Updates
Table 135. Intarcia Therapeutics Company Information
Table 136. Intarcia Therapeutics Description and Business Overview
Table 137. Intarcia Therapeutics GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Intarcia Therapeutics GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 139. Intarcia Therapeutics Recent Developments/Updates
Table 140. Nanexa AB Company Information
Table 141. Nanexa AB Description and Business Overview
Table 142. Nanexa AB GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Nanexa AB GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 144. Nanexa AB Recent Developments/Updates
Table 145. The General Hospital Corp Company Information
Table 146. The General Hospital Corp Description and Business Overview
Table 147. The General Hospital Corp GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. The General Hospital Corp GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 149. The General Hospital Corp Recent Developments/Updates
Table 150. QuiaPEG Pharmaceuticals Ab Company Information
Table 151. QuiaPEG Pharmaceuticals Ab Description and Business Overview
Table 152. QuiaPEG Pharmaceuticals Ab GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. QuiaPEG Pharmaceuticals Ab GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 154. QuiaPEG Pharmaceuticals Ab Recent Developments/Updates
Table 155. Qilu Pharmaceutical Company Information
Table 156. Qilu Pharmaceutical Description and Business Overview
Table 157. Qilu Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Qilu Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 159. Qilu Pharmaceutical Recent Developments/Updates
Table 160. Huadong Medicine Company Information
Table 161. Huadong Medicine Description and Business Overview
Table 162. Huadong Medicine GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Huadong Medicine GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 164. Huadong Medicine Recent Developments/Updates
Table 165. Jiuyuan Gene Engineering Company Information
Table 166. Jiuyuan Gene Engineering Description and Business Overview
Table 167. Jiuyuan Gene Engineering GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Jiuyuan Gene Engineering GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 169. Jiuyuan Gene Engineering Recent Developments/Updates
Table 170. Benemae Pharmaceutical Company Information
Table 171. Benemae Pharmaceutical Description and Business Overview
Table 172. Benemae Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Benemae Pharmaceutical GLP-1 Targeted Peptide Weight Loss Drugs Product
Table 174. Benemae Pharmaceutical Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. GLP-1 Targeted Peptide Weight Loss Drugs Distributors List
Table 178. GLP-1 Targeted Peptide Weight Loss Drugs Customers List
Table 179. GLP-1 Targeted Peptide Weight Loss Drugs Market Trends
Table 180. GLP-1 Targeted Peptide Weight Loss Drugs Market Drivers
Table 181. GLP-1 Targeted Peptide Weight Loss Drugs Market Challenges
Table 182. GLP-1 Targeted Peptide Weight Loss Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of GLP-1 Targeted Peptide Weight Loss Drugs
Figure 2. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Share by Type: 2025 & 2032
Figure 4. Liraglutide Product Picture
Figure 5. Semaglutide Product Picture
Figure 6. Tirzepatide Product Picture
Figure 7. Others Product Picture
Figure 8. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Share by Application: 2025 & 2032
Figure 10. Treatment of Type 2 Diabetes
Figure 11. Obesity and Weight Management
Figure 12. Cardiovascular Risk
Figure 13. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global GLP-1 Targeted Peptide Weight Loss Drugs Sales (K Units), 2021–2032
Figure 16. Global GLP-1 Targeted Peptide Weight Loss Drugs Average Price (US$/Unit), 2021–2032
Figure 17. GLP-1 Targeted Peptide Weight Loss Drugs Report Years Considered
Figure 18. GLP-1 Targeted Peptide Weight Loss Drugs Sales Share by Manufacturers in 2025
Figure 19. Global GLP-1 Targeted Peptide Weight Loss Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global GLP-1 Targeted Peptide Weight Loss Drugs Players: Market Share by Revenue in GLP-1 Targeted Peptide Weight Loss Drugs in 2025
Figure 21. GLP-1 Targeted Peptide Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global GLP-1 Targeted Peptide Weight Loss Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa GLP-1 Targeted Peptide Weight Loss Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE GLP-1 Targeted Peptide Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of GLP-1 Targeted Peptide Weight Loss Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of GLP-1 Targeted Peptide Weight Loss Drugs by Type (2021–2032)
Figure 56. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of GLP-1 Targeted Peptide Weight Loss Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of GLP-1 Targeted Peptide Weight Loss Drugs by Application (2021–2032)
Figure 59. Global GLP-1 Targeted Peptide Weight Loss Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. GLP-1 Targeted Peptide Weight Loss Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232